NIH Funding Cuts: Efficiency vs Innovation

The Trump administration’s cuts to National Institutes of Health (NIH) funding have sparked concern across the healthcare and research sectors, halting studies and prompting protests from scientists. In a recent article published by MedCity News, Project Farma President, Anshul Mangal, weighs in, emphasizing the urgent need for institutions to secure alternative, sustainable funding sources. He notes a growing role for private-sector collaboration, especially in rare disease and oncology research. As NIH support becomes less reliable, Anshul underscores that the future of innovation depends on diversifying how groundbreaking science is funded and sustained.

Click here to read the full article, NIH Cuts: A Push for Efficiency or a Blow to US Healthcare Innovation?